Supply Chain Intelligence

Solid Biosciences Inc. Supply Chain

SLDB supply chain intelligence for Solid Biosciences Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

SLDB ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

6Suppliers
2Customers
2Debt Items
20Related Chains

Solid Biosciences Inc. Suppliers

TickerNameConfidenceEvidence
ICS-MAUGERI-S-P-A-SB ICS-MAUGERI-S-P-A-SB 90% We paid Maugeri an upfront license fee of €1.5 million, which was recorded as research and development expense during the second quarter of 2023.
UNIVERSITY-OF-PENNSYLVANIA UNIVERSITY-OF-PENNSYLVANIA 90% The Company also assumed from FA212 contingent development milestone payments of up to $ 4.2 million, regulatory milestone payments of up to $ 13.0 million, cumulative sales milestone payments of up …
UNIVERSITY-OF-WASHINGTON UNIVERSITY-OF-WASHINGTON 80% In 2015, we entered into a license agreement with the University of Washington, acting through UW CoMotion, under which we obtained an exclusive, royalty-bearing, sublicensable, worldwide license und…
KROS Keros Therapeutics, Inc. 72% Reciprocal relationship from KROS graph: nued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirement…
LXEO Lexeo Therapeutics, Inc. 72% Reciprocal relationship from LXEO graph: Reciprocal relationship from SLDB graph: Reciprocal relationship from LXEO graph: s, obtain marketing approval and ultimately commercialize them. If we are un…
TRDA Entrada Therapeutics, Inc. 72% Reciprocal relationship from TRDA graph: Reciprocal relationship from SLDB graph: Reciprocal relationship from TRDA graph: Reciprocal relationship from SLDB graph: Reciprocal relationship from TRDA g…

Solid Biosciences Inc. Customers

TickerNameConfidenceEvidence
LXEO Lexeo Therapeutics, Inc. 72% Reciprocal relationship from LXEO graph: Reciprocal relationship from SLDB graph: Reciprocal relationship from LXEO graph: ply, if any, could be identified and qualified. We may be unable to find a s…
TRDA Entrada Therapeutics, Inc. 72% Reciprocal relationship from TRDA graph: everal risks, including disruptions in supply, price increases or late deliveries. There are, in general, relatively few alternative sources of supply for sub…

Solid Biosciences Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SLDB-DEBT Debt stack $20.7M 90% Market cache reports total debt of $20.7M.
SLDB-DEBT-12575 Warrants outstanding: 49.35 90% xbrl warrant detail from xbrl 2025-12-31.

Solid Biosciences Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Solid Biosciences Inc..

Solid Biosciences Inc. Ownership

HolderNameConfidenceEvidence
SLDB-OWNER-PERCEPTIVE-ADVISORS-LLC PERCEPTIVE ADVISORS LLC 90% 13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 142 tracked holders.

Solid Biosciences Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BIAF bioAffinity Technologies, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
ATYR aTyr Pharma, Inc. 100.00 2
ARWR Arrowhead Pharmaceuticals, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
CPRX Catalyst Pharmaceuticals, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
RGNX REGENXBIO Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
TECX Tectonic Therapeutic, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
CABA Cabaletta Bio, Inc. 100.00 2
BMRN BioMarin Pharmaceutical Inc. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
IMNM Immunome, Inc. 100.00 2
View SLDB supply chain intel →

Explore the full interactive supply chain map for Solid Biosciences Inc..

Open SLDB supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map